Use of Concentrated Plasma-Derived Subcutaneous C1 Inhibitor as Long-Term Prophylaxis in an 8-Year- Old Child With Hereditary Angioedema

J Investig Allergol Clin Immunol. 2023 Jul 27;33(4):302-304. doi: 10.18176/jiaci.0855. Epub 2022 Aug 24.
No abstract available

Keywords: C1 inhibitor deficiency; Children; Hereditary angioedema; Long-term treatment; Management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioedemas, Hereditary* / drug therapy
  • Child
  • Complement C1 Inhibitor Protein / therapeutic use
  • Humans

Substances

  • Complement C1 Inhibitor Protein